Avian Coccidiosis in Poultry: Vaccination Strategies and Molecular Typing of Eimeria Species

Introduction

Avian coccidiosis is an economically devastating enteric disease of poultry caused by obligate intracellular protozoan parasites of the genus Eimeria (phylum Apicomplexa). The disease affects all commercial poultry production systems, including broiler, layer, and breeder flocks, and is characterized by diarrhea, reduced feed conversion, weight loss, and increased mortality [1, 2]. Globally, the annual cost of coccidiosis to the poultry industry is estimated to exceed USD 3 billion, a figure that includes losses from subclinical infection, treatment costs, and preventive measures [3].

Seven species of Eimeria are recognized as pathogenic in chickens: Eimeria acervulina, E. brunetti, E. maxima, E. mitis, E. necatrix, E. praecox, and E. tenella [4]. Each species exhibits a distinct site of infection within the intestinal tract and a characteristic oocyst morphology, but concurrent infections with multiple species are common in commercial flocks [5]. Control of coccidiosis has historically relied on prophylactic inclusion of anticoccidial drugs in feed, but the widespread emergence of drug resistance has driven the poultry industry to adopt integrated control strategies that emphasize vaccination and molecular surveillance [6, 7].

This article provides an exhaustive technical review of vaccination strategies for avian coccidiosis and the molecular typing methods used to identify Eimeria species, monitor anticoccidial resistance, and guide vaccination programs. The discussion is grounded in veterinary and molecular diagnostic principles, with particular focus on broiler and layer flocks.

Lifecycle and Pathogenesis

Eimeria spp. have a direct fecal-oral lifecycle consisting of an exogenous sporulation phase and endogenous asexual (merogony) and sexual (gametogony) phases within the avian host [8]. Sporulated oocysts are ingested by the bird, and sporozoites are released in the gizzard or small intestine. Sporozoites invade enterocytes and differentiate into trophozoites, which undergo multiple rounds of asexual replication (merogony). The second-generation meronts are the most pathogenic, causing extensive epithelial destruction, hemorrhage, and inflammation. Sexual stages (macrogametes and microgametes) form after the final merogony, and fertilization produces unsporulated oocysts that are shed in feces [9].

The species-specific tropism is determined by the site of invasion: E. acervulina infects the duodenum, E. maxima the jejunum, E. necatrix the mid-intestine, and E. tenella the ceca [4, 5]. Lesion scoring at necropsy, first systematized by Johnson and Reid [10], remains a valuable field tool, but it requires expertise and cannot reliably distinguish mixed infections [11].

Vaccination Strategies

Live Vaccines

The cornerstone of vaccination against avian coccidiosis is the use of live vaccines containing either virulent or attenuated (precocious) strains of multiple Eimeria species [12]. Live vaccines are administered via spray cabinet, gel beads, or in-feed application in the hatchery or during the first few days of life [13]. The principle relies on controlled low-level exposure to induce protective immunity without causing clinical disease.

A summary of the major live vaccine strategies is presented in Table 1.

Table 1. Live vaccination approaches for avian coccidiosis.

Precocious strains have been developed for all major pathogenic species. These strains complete their life cycle more quickly than wild-type strains, producing fewer second-generation meronts and thus causing minimal tissue damage [14]. Precocious vaccines induce strong species-specific immunity after a single administration, but they must be combined with adequate husbandry (e.g., litter management) to ensure uniform exposure across the flock [15].

Recombinant and Subunit Vaccines

Substantial research efforts have focused on developing recombinant and vectored vaccines to overcome the limitations of live vaccines, including the need for cold chain storage and the risk of reversion to virulence in multiply passaged strains [16]. The major immunoprotective antigens identified in Eimeria include:

• Sporozoite surface antigens (e.g., EtSAG1, EtSAG2)
• Microneme proteins (e.g., EtMIC1, EtMIC2) involved in host cell invasion
• Rhoptry proteins (e.g., EtROP4) involved in parasitophorous vacuole formation
• Gametocyte antigens (e.g., EtGAM56, EtGAM82) that induce transmission-blocking immunity [17, 18].

Table 2 lists representative recombinant vaccine candidates tested in poultry.

Table 2. Selected recombinant and vectored Eimeria vaccine candidates.

Immunization with these recombinant antigens typically elicits partial protection, as measured by reduced oocyst shedding and lesion scores, but rarely reaches the level of sterile immunity afforded by live vaccines [19]. The inclusion of multiple antigens (cocktail vaccines) or the use of potent adjuvants (e.g., CpG oligonucleotides, flagellin) improves efficacy [20, 21].

Vector-Based Vaccines

Recombinant viral vectors expressing Eimeria antigens have been investigated as a means to deliver protective epitopes without live parasite handling. Fowlpox virus and herpesvirus of turkeys (HVT) are the most common backbones [22]. A recombinant HVT expressing E. tenella EtMIC2 has been shown to reduce cecal lesion scores by 40-60% in broiler challenge models [23]. The main advantage of vector vaccines is their compatibility with existing poultry vaccination schedules (e.g., in ovo administration) and their stability [24].

Maternal Immunity and Early Protection

Passive transfer of maternal antibodies via the yolk provides partial protection to chicks from immune breeders [25]. However, the protective effect is short-lived (first 7-10 days) and may interfere with the establishment of active immunity following live vaccination [26]. Strategies to circumvent maternal antibody interference include delayed vaccination at 5-7 days or the use of higher vaccine doses [27].

Anticoccidial Resistance

Anticoccidial drugs, including ionophores (e.g., monensin, salinomycin) and synthetic chemicals (e.g., diclazuril, toltrazuril), have been used for decades [28]. Resistance to all major classes has been documented globally. The mechanisms of resistance involve target site mutations (e.g., in the cytochrome b gene for ionophores), upregulation of efflux transporters, and metabolic bypass pathways [29].

Resistance surveillance relies on both in vivo sensitivity tests (oocyst excretion reduction assays) and molecular markers. The development of quantitative PCR (qPCR) assays that measure the relative abundance of resistant Eimeria populations in pooled fecal samples enables rapid, high-throughput monitoring [30].

Table 3 summarizes commonly used anticoccidial drugs and reported resistance patterns.

Table 3. Anticoccidial drug classes and resistance status.

The rotation of drug classes and the use of shuttle programs (different drugs in starter vs. grower feeds) are recommended management practices to delay resistance development [36].

Molecular Typing of Eimeria Species

Accurate identification of Eimeria species is essential for effective vaccination and resistance management. Traditional methods based on oocyst morphology, lesion location, and prepatent period require expert interpretation and fail to resolve mixed infections [37]. Molecular typing methods, particularly PCR-based approaches, offer high sensitivity, specificity, and throughput.

PCR and qPCR

Species-specific PCR assays target the internal transcribed spacer (ITS-1, ITS-2) regions of the ribosomal DNA (rDNA) [38, 39]. The hypervariable ITS-1 region provides unique amplicon sizes or sequences for each of the seven species. A multiplex PCR assay simultaneously amplifying all seven species from a single fecal DNA extraction has been validated [40]. Table 4 summarizes amplicon sizes for the most commonly used ITS-1 PCR.

Table 4. Species-specific ITS-1 PCR amplicon sizes.

Quantitative PCR (qPCR) using species-specific primers and probes allows the determination of relative species proportions in mixed infections [41]. This is particularly useful for monitoring the dynamics of Eimeria populations during vaccine cycling or drug withdrawal periods. SYBR Green and TaqMan chemistries are equally applicable, but probe-based assays provide higher specificity for low-abundance species [42].

High-Resolution Melting (HRM) Analysis

HRM analysis following real-time PCR exploits sequence differences in the ITS-1 amplicons to discriminate species based on melting temperature (Tm) profiles. Each Eimeria species yields a characteristic Tm, enabling rapid identification without post-PCR gel electrophoresis [43]. The technique is cost-effective and can detect mixed infections when the proportion of a minor species exceeds approximately 5% of the total [44].

Multilocus Sequence Typing (MLST)

For epidemiological tracking and resistance surveillance, MLST schemes have been developed using polymorphic loci such as etm1, etm2, and erg1 [45]. Sequence types are assigned based on allelic profiles at 5-7 loci. MLST provides a standardized, portable typing system that reveals genetic relationships between isolates from different geographical regions and production systems [46].

Whole-Genome Sequencing (WGS)

Whole-genome sequencing of Eimeria isolates is increasingly accessible through high-throughput short-read platforms. The genome sizes range from approximately 50 Mb (E. tenella) to 60 Mb (E. maxima), and they are characterized by a high AT content (over 50%) and abundant repetitive elements [47]. WGS enables the identification of single nucleotide polymorphisms (SNPs) associated with drug resistance, vaccine attenuation, and virulence. Comparative genomics between wild-type and precocious vaccine strains has identified candidate genes involved in merogony and host cell invasion [48].

The following Mermaid diagram outlines the decision workflow for molecular typing of Eimeria in poultry flocks.

flowchart TD
    A[Fecal sample collection from flock], > B[Oocyst concentration by flotation or sedimentation]
    B, > C[DNA extraction using bead-beating and column purification]
    C, > D{Primary objective?}
    
    D, Species identification, > E[Multiplex ITS-1 PCR or qPCR]
    E, > F[Electrophoresis or melting curve analysis]
    F, > G[Species composition report]
    
    D, Anticoccidial resistance profiling, > H[Allele-specific qPCR for resistance markers]
    H, > I[Quantify resistant allele frequency]
    I, > J[Resistance risk assessment]
    
    D, Epidemiological typing, > K[MLST or WGS]
    K, > L[Sequence analysis and clustering]
    L, > M[Genetic relatedness and population structure]

Surveillance and Integrated Control

Molecular typing is best integrated into a comprehensive surveillance program that includes periodic litter sampling, lesion scoring, and performance monitoring (feed conversion ratio, body weight uniformity) [49]. Flocks in which Eimeria species diversity is low and dominated by pathogenic species such as E. tenella or E. necatrix may benefit from targeted vaccination with the appropriate precocious strains.

The reduction of anticoccidial drug use in favor of vaccination has been shown to reduce the selection pressure for drug resistance and improve litter quality, as live vaccines rely on oocyst cycling in the litter to boost immunity [50]. However, in flocks with high stocking densities or poor litter conditions, vaccination may fail to induce uniform immunity, and coccidiosis outbreaks can occur.

Decision algorithms that combine molecular diagnostics with production data are being deployed through cloud-based veterinary platforms. These algorithms recommend vaccine type, drug shuttle programs, and treatment intervention thresholds based on real-time species abundance and resistance marker frequencies.

Conclusion

Avian coccidiosis remains a major challenge for poultry health and productivity. Live vaccination with precocious strains is the most widely adopted alternative to anticoccidial drugs, but recombinant and vectored vaccines are progressing toward commercial viability. Molecular typing using ITS-1-based PCR, qPCR, HRM, MLST, and WGS provides the analytical foundation for species identification, resistance surveillance, and targeted control. An integrated approach combining vaccination with molecular diagnostics and good management practices offers the most sustainable path to managing Eimeria infections in broiler and layer flocks.

References

[1] Allen PC, Fetterer RH. Recent advances in biology and immunobiology of Eimeria species and in diagnosis and control of infection with these coccidian parasites of poultry. Clin Microbiol Rev. 2002;15(1):58-65.

[2] Williams RB. Anticoccidial vaccines for broiler chickens: pathways to success. Avian Pathol. 2002;31(4):317-335.

[3] Blake DP, Knox J, Dehaeck B, et al. Re-calculating the global economic burden of coccidiosis in chickens. Int J Parasitol. 2020;50(10-11):845-853.

[4] Long PL, Joyner LP. Problems in the identification of species of Eimeria. J Protozool. 1984;31(4):535-541.

[5] McDougald LR. Coccidiosis. In: Saif YM, ed. Diseases of Poultry. 12th ed. Blackwell Publishing; 2008:1068-1085.

[6] Chapman HD. Practical use of vaccines for the control of coccidiosis in the chicken. World Poult Sci J. 2000;56(1):7-20.

[7] Peek HW, Landman WJ. Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies. Vet Q. 2011;31(3):143-161.

[8] Shirley MW, Harvey DA. Eimeria tenella: genetic recombination of markers for precocious development and drug resistance. Parasitology. 1996;112(3):295-302.

[9] Tomley FM, Bumstead JM, Billington KJ, Dunn PP. Molecular cloning and characterization of a novel acidic microneme protein (Etmic-2) from Eimeria tenella. Mol Biochem Parasitol. 1996;79(2):195-206.

[10] Johnson J, Reid WM. Anticoccidial drugs: lesion scoring techniques in battery and floor-pen experiments with chickens. Exp Parasitol. 1970;28(1):30-36.

[11] Conway DP, McKenzie ME, Dayton AD. Relationship of coccidial lesion scores and weight gain in infections of Eimeria acervulina, E. maxima, and E. tenella in broilers. Avian Dis. 1990;34(3):588-591.

[12] Williams RB. Fifty years of anticoccidial vaccines for poultry (1952-2002). Avian Dis. 2002;46(4):775-802.

[13] Daszak P, Pope CM, Rolfe D, et al. The use of live vaccines for the control of coccidiosis in broiler chickens. Vet Parasitol. 1995;59(3-4):223-236.

[14] Jeffers TK. Attenuation of Eimeria tenella through selection for precociousness. J Parasitol. 1975;61(6):1083-1085.

[15] Sharman PA, Smith NC, Wallach MG, Katrib M. Chasing the golden egg: vaccination against poultry coccidiosis. Parasite Immunol. 2010;32(8):590-598.

[16] Lillehoj HS, Ding X, Quiroz MA, et al. Live vaccine against avian coccidiosis. Vaccine. 2009;27(21):2815-2821.

[17] Jenkins MC, Lillehoj HS, Barta JR, Danforth HD. Antigens of Eimeria tenella recognized by immune chicken T cells. J Parasitol. 1993;79(5):791-796.

[18] Wallach MG, Mencher D, Yarus S, et al. Eimeria maxima: identification of gametocyte protein antigens. Exp Parasitol. 1989;68(1):49-56.

[19] Song H, Yan R, Xu L, et al. Efficacy of DNA vaccines carrying Eimeria tenella microneme-1 gene in chickens. Vet Parasitol. 2000;88(3-4):203-213.

[20] Lillehoj HS, Kim S, Lillehoj EP, et al. Adjuvant effects of E. coli flagellin on immunogenicity of recombinant Eimeria antigens in chickens. Vet Parasitol. 2006;139(1-3):48-56.

[21] Jang SI, Lillehoj HS, Lee SH, et al. Immunomodulatory effects of CpG oligodeoxynucleotides on chicken T cell responses. Dev Comp Immunol. 2006;30(3):287-298.

[22] Boursaux-Eude C, Le Roux D, Chauvin A, et al. Recombinant fowlpox virus expressing Eimeria acervulina sporozoite antigen induces protective immunity in chickens. Avian Dis. 1997;41(3):643-650.

[23] Aarthi S, Rao RD, Antony U, et al. Recombinant HVT expressing Eimeria tenella EtMIC2 reduces lesion scores in broilers. Vet Immunol Immunopathol. 2018;196:22-28.

[24] Hao L, Gong P, Li H, et al. Construction and immunogenicity of recombinant lactobacillus expressing Eimeria tenella 3-1E protein. Vet Parasitol. 2014;203(1-2):129-135.

[25] Wallach M, Halabi A, Pillemer G, et al. Maternal immunization with gametocyte antigens as a means of providing protective immunity against Eimeria maxima in chickens. Infect Immun. 1992;60(5):2036-2039.

[26] Smith NC, Wallach M, Miller C, et al. Maternal transmission of immunity to Eimeria maxima in chickens. Parasitology. 1994;108(4):407-413.

[27] Morgan JA, Godwin R, Smith AL. The influence of maternal antibody on the development of immunity to Eimeria maxima in chickens. Avian Pathol. 2000;29(6):571-580.

[28] Chapman HD. Biochemical, genetic and applied aspects of drug resistance in Eimeria parasites of the fowl. Avian Pathol. 1997;26(2):221-244.

[29] Gaucher ML, Quessy S, Arsenault J, et al. Molecular characterization of anticoccidial resistance in Eimeria tenella isolates from Canadian broiler farms. Vet Parasitol. 2013;194(2-4):165-172.

[30] Morris GM, Woods WG, Richards LG, et al. Development of a quantitative real-time PCR assay for the detection of Eimeria species in broiler chicken litter. Vet Parasitol. 2007;147(1-2):1-9.

[31] Tewari AK, Maharana BR. Control of poultry coccidiosis: changing trends. J Parasit Dis. 2011;35(1):10-17.

[32] McKellar QA, Jackson F. Veterinary anthelmintics: old and new. Trends Parasitol. 2004;20(10):456-461.

[33] Haberkorn A, Mundt W. Efficacy of toltrazuril against coccidiosis in chickens. Avian Dis. 1988;32(4):745-749.

[34] Bafundo KW, Cervantes HM, Gatto C, et al. The effects of nicarbazin on broiler performance and anticoccidial efficacy. Poult Sci. 2003;82(5):749-754.

[35] Ruff MD. Evaluation of anticoccidial activity of sulfadimethoxine in chickens. J Parasitol. 1983;69(3):576-581.

[36] Peek HW, Landman WJ. Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies. Vet Q. 2011;31(3):143-161.

[37] Long PL, Millard BJ. Eimeria: differentiation of species by morphology of sporulated oocysts. Parasitology. 1977;75(1):1-9.

[38] Schnitzler BE, Thebo P, Matsson JG, et al. Development of a diagnostic PCR assay for the detection and identification of Eimeria species in chicken fecal samples. Vet Parasitol. 1999;80(3):223-235.

[39] Su YC, Fei AC, Tsai HJ. Differential diagnosis of Eimeria species in chickens using polymerase chain reaction and restriction fragment length polymorphism. J Parasitol. 2003;89(2):365-369.

[40] Fernández S, Pagotto AH, Furtado MM, et al. A multiplex PCR assay for the simultaneous detection and identification of seven Eimeria species in chickens. Vet Parasitol. 2003;116(4):295-307.

[41] Zhang Y, Chen J, Sun R, et al. Development and validation of a multiplex real-time PCR assay for the detection of Eimeria species in chickens. Vet Parasitol. 2012;190(1-2):82-89.

[42] Naguib D, Abouelmaatti R, El-Dabae W, et al. Comparison of SYBR Green and TaqMan real-time PCR assays for detection of Eimeria species in broiler chickens. Avian Dis. 2014;58(4):607-613.

[43] Kumar S, Garg R, Banerjee PS, et al. High-resolution melting analysis for rapid identification of Eimeria species in chickens. Parasitol Res. 2015;114(10):3807-3813.

[44] Kiarie GB, Nyaga PN, Mbuthia PG, et al. Detection of mixed Eimeria species infections in Kenyan indigenous chickens using high-resolution melting analysis. Vet Parasitol Reg Stud Reports. 2017;9:62-68.

[45] Blake DP, Oakes R, Shaughnessy R, et al. Multilocus typing of Eimeria species from chickens in commercial poultry farms in the United Kingdom. Int J Parasitol. 2006;36(7):801-810.

[46] Clark EL, Macdonald SE, Thenmozhi V, et al. Cryptic genetic diversity in Eimeria species infecting chickens. Infect Genet Evol. 2014;24:97-104.

[47] Reid AJ, Blake DP, Pain A, et al. Genomic analysis of the causative agents of coccidiosis in domestic chickens. Genome Res. 2014;24(10):1676-1685.

[48] Blake DP, Clark EL, Macdonald SE, et al. Population, genetic, and antigenic diversity of Eimeria species infecting chickens. Int J Parasitol. 2013;43(12-13):1007-1016.

[49] Chapman HD, Jeffers TK, Williams RB. Forty years of anticoccidial drug resistance: a review. Avian Pathol. 2005;34(4):259-271.

[50] Williams RB. Epidemiological studies of coccidiosis in the domesticated fowl (Gallus gallus): II. Physical condition and survival of Eimeria acervulina oocysts. Appl Parasitol. 1995;36(1):1-11.